Source: NutraIngredients-USA

BIO-CAT: Bio-Cat launches RCT to examine enzyme mix on digestive health markers

Virginia-based Bio-Cat, Inc. is sponsoring a clinical trial at the University of Illinois at Urbana-Champaign to investigate the efficacy of a digestive enzyme blend designed to improve protein digestion and gastrointestinal tolerance.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Ed Schuler's photo - Founder & CEO of BIO-CAT

Founder & CEO

Ed Schuler

CEO Approval Rating

90/100